AUD299.88
0.45% today
Australia, Sep 08, 08:10 am CET
ISIN
AU000000COH5
Symbol
COH

Cochlear Stock price

AUD299.88
-9.39 3.04% 1M
+33.03 12.38% 6M
+12.31 4.28% YTD
+12.93 4.51% 1Y
+91.72 44.06% 3Y
+118.92 65.72% 5Y
+227.57 314.72% 10Y
+273.20 1,023.95% 20Y
Australia, Closing price Mon, Sep 08 2025
+1.35 0.45%
ISIN
AU000000COH5
Symbol
COH

Key metrics

Basic
Market capitalization
AUD19.5b
Enterprise Value
AUD19.5b
Net debt
positive
Cash
AUD275.7m
Shares outstanding
65.4m
Valuation (TTM | estimate)
P/E
50.3 | 42.7
P/S
8.3 | 7.4
EV/Sales
8.3 | 7.4
EV/FCF
144.4
P/B
10.0
Dividends
DPS
AUD4.30
Yield 1Y | 5Y
1.4% | 1.5%
Growth 1Y | 5Y
4.9% | 21.9%
Payout 1Y | 3Y
72.5% | 73.5%
Increased
5 Years
Financials (TTM | estimate)
Revenue
AUD2.3b | AUD2.6b
EBITDA
- | AUD723.2m
EBIT
AUD532.5m | AUD613.7m
Net Income
AUD388.9m | AUD456.8m
Free Cash Flow
AUD135.0m
Growth (TTM | estimate)
Revenue
4.8% | 12.0%
EBITDA
- | -
EBIT
0.2% | 15.3%
Net Income
9.0% | 17.5%
Free Cash Flow
-54.9%
Margin (TTM | estimate)
Gross
74.2%
EBITDA
- | 27.6%
EBIT
22.7%
Net
16.6% | 17.4%
Free Cash Flow
5.8%
Financial Health
Equity Ratio
69.0%
Return on Equity
19.9%
ROCE
24.0%
ROIC
19.0%
Debt/Equity
0.1
More
EPS
AUD5.9
FCF per Share
AUD2.1
Short interest
-
Employees
5k
Rev per Employee
AUD460.0k
Show more

Is Cochlear a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Cochlear Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Cochlear forecast:

9x Buy
45%
9x Hold
45%
2x Sell
10%

Analyst Opinions

20 Analysts have issued a Cochlear forecast:

Buy
45%
Hold
45%
Sell
10%

Financial data from Cochlear

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,343 2,343
5% 5%
100%
- Direct Costs 606 606
12% 12%
26%
1,738 1,738
2% 2%
74%
- Selling and Administrative Expenses 940 940
5% 5%
40%
- Research and Development Expense 292 292
5% 5%
12%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 533 533
0% 0%
23%
Net Profit 389 389
9% 9%
17%

In millions AUD.

Don't miss a Thing! We will send you all news about Cochlear directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.

Head office Australia
CEO Diggory Howitt
Employees 5,047
Founded 1983
Website www.cochlear.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today